Showing results (111-120 of 135) with videos related to
Sort By:
Pageof 14
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 9, 2019
Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trialJesus S Mora, Angela Genge, Adriano Chio, et al.Nature Communications|August 17, 2023
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosisJessica Mandrioli, Roberto D'Amico, Elisabetta Zucchi, et al.Neurology|March 10, 2019
Revised Airlie House consensus guidelines for design and implementation of ALS clinical trialsLeonard H van den Berg, Eric Sorenson, Gary Gronseth, et al.Journal of Neurology|August 16, 2015
C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian populationAntonino Cannas, Paolo Solla, Giuseppe Borghero, et al.Neurology|October 6, 2017
Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trialsRuben P A van Eijk, Ashley R Jones, William Sproviero, et al.Human Molecular Genetics|September 18, 2015
Glucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell deathMarcus Keatinge, Hai Bui, Aswin Menke, et al.Brain : a Journal of Neurology|March 23, 2013
A genetic study of Wilson's disease in the United KingdomAlison J Coffey, Miranda Durkie, Stephen Hague, et al.Brain Communications|October 28, 2021
SCFD1 expression quantitative trait loci in amyotrophic lateral sclerosis are differentially expressedAlfredo Iacoangeli, Isabella Fogh, Sashika Selvackadunco, et al.The Lancet. Neurology|October 11, 2014
Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling studyAmmar Al-Chalabi, Andrea Calvo, Adriano Chio, et al.JAMA Neurology|March 24, 2025
Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical TrialJeremy M Shefner, Merit E Cudkowicz, Angela Genge, et al.Pageof 14